Strategic partnership Meridian Life Science partners with global players and recently announced collaboration with 4Bases SA to enable rapid, globally scalable next-generation sequencing workflows, signaling openness to co-development and expanded distribution opportunities in sequencing reagents and services.

NGS expansion The launch of Lyophilized NGS Enzymatic DNA Fragmentation Kit highlights an opportunity to cross-sell enzymatic fragmentation, nucleotides, and related library prep reagents to customers adopting next-generation sequencing workflows.

Diagnostics focus With a long track record in immunoassays, antigens, antibodies, and diagnostic reagents, there is potential to upsell contract R&D and manufacturing services to in vitro diagnostic (IVD) manufacturers seeking scalable production and quality-driven supply.

Quality and support Robust quality systems and dedicated R&D and manufacturing teams position Meridian to target customers needing reliable GMP-like capabilities, process development, and technical support for assay development and manufacturing scale-up.

Market breadth A diversified product line spanning blocking reagents, enzymes, PCR/qPCR reagents, and nucleotides enables bundle offerings and cross-selling across multiple life science segments, including molecular diagnostics and immunodiagnostics.